Literature DB >> 9636068

Secretory phospholipase A2 and lipoprotein lipase enhance 15-lipoxygenase-induced enzymic and nonenzymic lipid peroxidation in low-density lipoproteins.

J Neuzil1, J M Upston, P K Witting, K F Scott, R Stocker.   

Abstract

The oxidation of low-density lipoprotein (LDL) is thought to contribute to atherogenesis. 15-Lipoxygenase (15LO) induces LDL oxidation, and phospholipase A2 enhances this process [Sparrow, C. P. , Parthasarathy, S., and Steinberg, D. (1988) J. LipidRes. 29, 745-753]. As the underlying mechanism of the enhancing effect has not been investigated previously, we here show that in the presence of soybean 15LO (SLO) or human 15LO (rhLO), the addition of lipoprotein lipase, porcine pancreatic, or human type IIa secretory phospholipase A2 (sPLA2) greatly enhanced the accumulation of hydro(pero)xides of all major classes of LDL's lipids. Hydroperoxides of free fatty acids accumulated exclusively as enzymic products with kinetics reflecting both the formation of free fatty acids and the initial 'build-up' of alpha-tocopheroxyl radical. In contrast, hydroperoxides of cholesteryl esters and phosphatidylcholine accumulated linearly over comparatively longer periods of time and, in the case of rhLO, well beyond inactivation of the oxygenase. With SLO, formation of oxidized esterified lipids occurred nonenzymically, independent of the presence of lipase and despite the oxygenase remaining active until the end of the incubation. Enhancement of rhLO-induced LDL lipid peroxidation by sPLA2 was eliminated by a neutralizing anti-sPLA2 antibody, indicating that lipolytic activity was required for this effect. LDL depleted of alpha-tocopherol was resistant to oxidation by 15LO alone, whereas lipase overcame this resistance, demonstrating that lipases enhance 15LO-induced enzymic and nonenzymic peroxidation of LDL lipids. This is likely due to provision of free fatty acid substrate, resulting in an enhanced rate of free radical formation which itself causes nonenzymic peroxidation of esterified lipids. As lipases and 15LO are present in atherosclerotic lesions, our findings could be of pathophysiological significance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636068     DOI: 10.1021/bi9730745

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.

Authors:  Hiroyasu Sato; Rina Kato; Yuki Isogai; Go-ichi Saka; Mitsuhiro Ohtsuki; Yoshitaka Taketomi; Kei Yamamoto; Kae Tsutsumi; Joe Yamada; Seiko Masuda; Yukio Ishikawa; Toshiharu Ishii; Tetsuyuki Kobayashi; Kazutaka Ikeda; Ryo Taguchi; Shinji Hatakeyama; Shuntaro Hara; Ichiro Kudo; Hiroyuki Itabe; Makoto Murakami
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

2.  Successful Identification of Cardiac Troponin Calcium Sensitizers Using a Combination of Virtual Screening and ROC Analysis of Known Troponin C Binders.

Authors:  Melanie L Aprahamian; Svetlana B Tikunova; Morgan V Price; Andres F Cuesta; Jonathan P Davis; Steffen Lindert
Journal:  J Chem Inf Model       Date:  2017-11-16       Impact factor: 4.956

3.  Serum biomarkers for acute hepatotoxicity of Echis pyramidum snake venom in rats.

Authors:  Abdulrahman K Al Asmari; Haseeb A Khan; Faisal A Banah; Ahmed A Al Buraidi; Rajamohammed A Manthiri
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Maslinic acid modulates secreted phospholipase A2-IIA (sPLA2-IIA)-mediated inflammatory effects in macrophage foam cells formation.

Authors:  Wei Hsum Yap; Bee Kee Ooi; Nafees Ahmed; Yang Mooi Lim
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

5.  Macrophage cholesteryl ester hydrolases and hormone-sensitive lipase prefer specifically oxidized cholesteryl esters as substrates over their non-oxidized counterparts.

Authors:  J Belkner; H Stender; H G Holzhütter; C Holm; H Kühn
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

6.  LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein.

Authors:  Liana Asatryan; Ryan T Hamilton; J Mario Isas; Juliana Hwang; Rakez Kayed; Alex Sevanian
Journal:  J Lipid Res       Date:  2004-10-16       Impact factor: 5.922

Review 7.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

8.  Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.

Authors:  Yesseny Vasquez-Martinez; Rachana V Ohri; Victor Kenyon; Theodore R Holman; Silvia Sepúlveda-Boza
Journal:  Bioorg Med Chem       Date:  2007-08-22       Impact factor: 3.641

9.  Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFalpha-stimulated human endothelial cells.

Authors:  K Sonoki; M Iwase; N Sasaki; S Ohdo; S Higuchi; Y Takata; M Iida
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

10.  Role of secretory phospholipase A₂ in women with metabolic syndrome.

Authors:  D Pop; A Sitar-Taut; G Bodisz; D Zdrenghea; M Cebanu; L Stanca
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.